chr13-48411503-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001162498.3(LPAR6):c.921G>T(p.Trp307Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.012 in 1,612,538 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001162498.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LPAR6 | NM_001162498.3 | c.921G>T | p.Trp307Cys | missense_variant | 1/1 | ENST00000620633.5 | |
RB1 | NM_000321.3 | c.1695+30060C>A | intron_variant | ENST00000267163.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LPAR6 | ENST00000620633.5 | c.921G>T | p.Trp307Cys | missense_variant | 1/1 | 5 | NM_001162498.3 | P1 | |
RB1 | ENST00000267163.6 | c.1695+30060C>A | intron_variant | 1 | NM_000321.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00828 AC: 1259AN: 152104Hom.: 8 Cov.: 32
GnomAD3 exomes AF: 0.00875 AC: 2179AN: 249030Hom.: 15 AF XY: 0.00870 AC XY: 1172AN XY: 134644
GnomAD4 exome AF: 0.0124 AC: 18063AN: 1460316Hom.: 109 Cov.: 31 AF XY: 0.0122 AC XY: 8828AN XY: 726460
GnomAD4 genome AF: 0.00826 AC: 1258AN: 152222Hom.: 8 Cov.: 32 AF XY: 0.00838 AC XY: 624AN XY: 74430
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | LPAR6: BP4, BS1, BS2; RB1: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 17, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Retinoblastoma Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | Aug 22, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at